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Summary.-Administration of04125% formylhydrazine in drinking water to 6-week-
old randomly bred Swiss albino mice for life, induced lung tumours. Compared to un-
treated controls, the lung-tumour incidence rose from 15 to 94% in the females and
from 22 to 100% in the males. The treatment had no detectable tumorigenic effect in
other organs.
THE PRESENT WORK is part ofsystematic
studies on the carcinogenicity and mode of
action of hydrazine analogues. This class
of chemicals is apparently widely distri-
butedintheenvironment due toindustrial,
agricultural and medicinal use (The Merck
Index, 1976). In addition they occur
naturally in mushrooms, tobacco and
moulds (Levenberg, 1961; List and Luft,
1968; Toth, 1975; Schmeltz, Abidi and
Hoffmann, 1977; LaRue, 1977). Therefore
the human population may be exposed to
them to a considerable degree.
It was shown in earlier investigations
that N-methyl-N-formylhydrazine, an in-
gredient of the edible false morel mush-
room induced tumours in mice and
hamsters (Toth, 1977; Toth and Nagel,
1978). Under conditions mimicking the
milieu ofthehumanstomach, N-methyl-N-
formylhydrazine breaks down to methyl-
hydrazine, a known tumour-inducer in
mice and hamsters (Toth, 1977; Toth and
Shimizu, 1973; Nagel et al., 1977). Formyl-
hydrazine was selected for this study to
find whether this portion ofthe N-methyl-
N-formylhydrazine molecule also posessess
carcinogenic activity.
Thisreportrecords the tumorigenicity of
formylhydrazine administered in drinking
water for life to Swiss mice.
MATERIALS AND METHODS
Swiss albino mice from the Eppley colony
randomly bred by us since 1951 were used.
They were housed in plastic cages with
granular cellulose bedding, separated
according to sex into groups of 10, and given
Wayne Lab-Blox diet in regular pellets
(Allied Mills, Inc., Chicago Ill.) and tap-
water or the chemical solution ad libitum, as
described below.
The chemical used was formylhydrazine
(FH, formic acid hydrazide) (Fig.), mol.wt
60-06, m.p. 54-56°C, purity > 99%, ob-





Fic. Chemical structure of formylhydrazine.
A toxicity study was carried out before the
chronic experiment. Five dose levels of FH
(1, 0-5, 0-25, 0-125 and 0.0625%) were
administered in the drinking water for 35
days to Swiss mice. By taking into account 4
parameters-survival rates, body weights,
chemical consumption and histological
changes-the 0.125% dose was found to be
suitable for the lifelong treatments. This
toxicity technique was developed in this
laboratory (Toth, 1972a).
The solution was prepared thrice weekly,
and the total consumption of water contain-
ing FH was measured at the same intervals
during the treatment period. The solution
was contained in brown bottles because ofthe
possible light sensitivity ofthe chemical. The
0-125% solution of FH used for the chronic
experiment was analysed by gas chromato-
graphy after standing 48h at room tempera-
ture and was found to contain > 98% oftheFORMYLHYDRAZINE CARCINOGENESIS
original compound unchanged. The chronic-
exposure group and the controls were as
follows:
Group 1 -FH wasdissolved inthe drinking
water as a 0-125% solution and was given for
the life-span of 50 female and 50 male mice
that were 6 weeks (43 days) old at the begin-
ning of the experiment. The average daily
consumption per animal of water containing
FH was 4-9 ml for the females and 5-9 ml for
the males. Thus the average daily intake of
FH was 6-1 mg for a female and 7-3 mg for a
male.
Group 2.-As an untreated control, 100
female and 100 male mice were kept and
observed from weaning (5 weeks of age).
The experimental and control animals were
carefully checked and weighed at weekly
intervals, and the gross pathological changes
were recorded. The animals were either
allowed to die or killed with ether when found
in poor condition. Complete necropsies were
performed on all animals. All organs were
examined macroscopically and fixed in
buffered 10% formalin. Histological studies
were made on liver, spleen, kidney, bladder,
thyroid, heart, pancreas, ovaries, testis, brain,
nasal turbinae, and at least 4 lobes of the
lungs ofeach mouse, as wellas onthose organs
showing gross pathological changes. Sections
from these tissues were stained routinely
with haematoxylin and eosin.
RESULTS
The survival rates after weaning are
recorded in Table I. As can be seen, the
treatment in both sexes significantly
shortened survival compared with that of
untreated controls.
Thenumbers, andpercentages ofanimals
with tumours, and their ages at death
(latent periods) are summarized in Table
II. The detailed incidences oflung tumours
are described below.
Lung tumours
Of the treated females, 47 (94%)
developed 531 lung tumours. Of these,
23 mice had 149 adenomas and 24
mice had 331 adenomas and 51 adeno-
carcinomas. Their average age at death
was 68 weeks, the first tumour being
observed at the 43rd week and the last at
the 89th week. In the treated males, 50
(100%) developed 400 such neoplasms. Of
these, 26 mice had 114 adenomas and 24
mice had 237 adenomas and 49 adeno-
carcinomas. Their average ageatdeathwas
64 weeks, the first tumour being seen at
the 37th week and the last at the 88th
week.
Grossly and histopathologically, all
observed lung lesions were similar to those
described earlier (Toth, Magee and Shubik,
1964; Toth and Shimizu, 1974).
Other tumours
In a few instances, other types of
tumours were found in the various groups
shown in Table II. Because of their low
numbers, their appearance cannot be
attributed to the treatment.
DISCUSSION
The present finding demonstrates the
tumorigenicity of formylhydrazine ad-
ministered in drinking water daily to
Swiss mice for life. The incidence of lung
tumours increased from 15 to 94% in
females and from 22 to 100% in males,
when compared with the untreated con-
TABLE I.-Treatment and Survival Rates in Formylhydrazine (FH)-treated and
Control Swiss Mice
Initial No.
Group Treatment and sex




No. of survivors (age in weeks)
, t A~~~~~~
10 20 30 40 50 60 70 80 90 100
50 49 49 49 47 36 19 3 0
50 50 50 49 43 27 13 3 0
2 Untreated
controls 100S9 100 100 99 96 95 91 78 66 45
loo1 100 98 92 88 80 62 36 17 11
28 13 2 0
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trols. The statistical analysis, carried out
using Fisher's exact test (Armitage, 1971)
for 2 x 2tables, showsthattreatedfemales
P < 0 0001 and in males P < 0-0001, the
incidence of lung neoplasms was signifi-
cantly higher than in the corresponding
controls Histological examination showed
the characteristic appearance of adenomas
andadenocarcinomas of the lungs.
The edible wild mushroom, the false
morel Gyromitra esculenta (Miller, 1972)
contains up to 500 parts/106 N-methyl-N-
formylhydrazine (Schmidlin-Mesz'aros,
1974; Wallcave and Conrad (unpubl.).
This compound, administered orally, in-
duced tumours in the lungs, liver, gall
bladder and bile ducts of Swiss mice
(Toth and Nagel, 1978) and in nearly the
same organs in Syrian golden hamsters
(Toth, 1977). Under certain in vitro
conditions, and also in the mouse stomach,
N-methyl-N-formylhydrazine breaksdown
to methylhydrazine (Nagel et al., 1977),
which in earlier investigations produced
lung tumours in mice (Toth, 1972b), as
well as malignant histiocytomas and
tumours in the caecum of hamsters (Toth
and Shimizu, 1973). The current study is
the next logical step along this line to
assess the possible tumorigenicity of the
remaining portion of the N-methyl-N-
formylhydrazine molecule. Formylhydra-
zine exhibited strong tumour-inducing
action here, and this helps to explain the
highly carcinogenic nature of N-methyl-
N-formylhydrazine. In addition, the
present work is also a continuation of
studies designed to reveal the relative
carcinogenic potencies of mono- and
dialkyl-hydrazines. A series ofcompounds,
such as methyl-, 1,2-dimethyl-, and l,l-
dimethyl-hydrazines, provided valuable
information on the relationship between
chemical structure and carcinogenic
activity (Toth and Wilson, 1971; Toth,
1972b, 1973).
To date, around 40hydrazine derivatives
are known to induce tumours in labora-
tory animals (Toth, 1975, 1978). Interest-
ingly enough, the human population is
exposed to about halfofthese compounds.
It appears therefore that this class of
chemicals is relevant to environmental
carcinogenesis, even though it has thus far
received limited attention. Twenty of
these 40 hydrazines were first shown to be
carcinogenic in this laboratory.
I wish to thank Dr Kashinath Patil for the statis-
tical analysis. This work was supported by USPHS
Contract NOI CP33278 from the National Cancer
Institute, NIH.
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